4 Haematological Malignancy Diagnostic Service, St James's University Hospital . Using a genotype-driven, phenotype-neutral approach to discover a genetic cause of inflammatory disease, researchers have identified a new disorder arising . An . Causes Variants (also called mutations) in the UBA1 gene cause VEXAS syndrome. The clinical manifestations found in these 116 patients are similar to those reported in the initial study but with a higher rate of association with MDS (50%). VEXAS is caused by a . What's even more interesting is that this condition is caused by a postzygotic somatic mutation, an apparently underrecognized cause of disease that we . As a result, they feel as though the disease is most likely more common than researchers believe. 2 Leeds Institute of Medical Research, University of Leeds, Leeds, United Kingdom. It mostly occurs in male patients and presents with hematological abnormalities such as cytopenia and cytoplasmic vacuoles in erythroid and myeloid cells in the bone marrow. It is crucial for the dermatologist to recognize the distinctive clinical and histological features. Researchers from the National Institutes of Health (NIH) have discovered a new inflammatory disorder called vacuoles, E1 enzyme, X-linked, autoinflammatory and somatic syndrome (VEXAS), which is caused by mutations in the UBA1 gene.VEXAS causes symptoms that included blood clots in veins, recurrent fevers, pulmonary abnormalities and vacuoles (unusual cavity-like structures) in myeloid cells. VEXAS, an acronym for vacuoles, E1 enzyme, X-linked, autoinflammatory and somatic syndrome, is a newly defined, adult-onset genetic disease that typically affects males. VEXAS is an acronym defined as follows: V A multiprofessional approach to management with swift referral to . This is the major E1 enzyme responsible for initiating ubiquitylation. [1] [2] [3] [4] [5] The name VEXAS is an acronym deriving from the core features of disease: [6] AML can cause fever, infection, hemorrhage, and anemia, damage the patient's health and even threaten the patient's life. Researchers provide a retrospective update on hematological manifestations in 16 patients evaluated at the National Institutes of Health. VEXAS syndrome is a monogenic disease caused mostly by somatic variants affecting methionine-41 (p.Met41) in UBA1, which was first reported in 2020. The disease affects only men because it is. VEXAS syndrome is a newly discovered disease which researchers determined is caused by mutations in UBA1 (a gene found in bone marrow stem cells). The VEXAS syndrome is a recently identified autoinflammatory systemic disease. Based on this process, VEXAS syndrome is classified as an autoinflammatory disease. VEXAS syndrome (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) is a monogenic disease of adulthood caused by somatic mutations in UBA1 in hematopoietic progenitor cells. What is VEXAS Syndrome? VEXAS is a highly refractory and potentially fatal syndrome associated with specific cutaneous and soft-tissue manifestations, often as the initial presenting complaint. vexas syndrome (vacuoles, e1 enzyme, x-linked, autoinflammatory, somatic) was first reported in 2020 in 25 men with adult-onset inflammatory disease and myeloid dysplasia. Vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome is an adult-onset inflammatory disorder resulting from somatic sequence variations in the X-linked UBA1 gene. The disease is due to an acquired somatic mutation of the UBA1 gene, which encodes for the E1 enzyme, which in turn is responsible for the ubiquitination of proteins. 2 vexas is caused by acquired somatic mutations at methionine 41 (p.met41) of uba1, the major e1 enzyme The disease affects only men because it is caused by genetic mutations on the X chromosome, and men carry only one X chromosome. VEXAS causes symptoms that included blood clots in veins, recurrent fevers, pulmonary abnormalities and vacuoles (unusual cavity-like structures) in myeloid cells.

VEXAS causes symptoms that included blood clots in veins, inflammation of the cartilage, abnormalities in the lung system, recurring fevers and pulmonary abnormalities and vacuoles (unusual cavity-like structures) in myeloid cells, the scientists reported in their findings in the New England Journal of Medicine. VEXAS syndrome causes unexplained fevers, painful skin rashes and affects the bone marrow resulting in a reduced number of red and white blood cells. This gene encodes the major E1 enzyme involved in the activation of ubiquitin, a small regulatory protein which attaches to substrate proteins (ubiquitylation). 3 National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD. VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) is caused by acquired somatic mutations at Methionine 41 (p.Met41) of UBA1 on chromosome X. VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) syndrome is a newly-described adult-onset inflammatory syndrome characterized by vacuoles in myeloid and erythroid precursor cells and somatic mutations affecting methionine-41 (p.Met41) in UBA1. 1 using a genotype-first approach to disease discovery, acquired mutations were identified in all cases of vexas in the uba1 gene, which encodes for the master enzyme of The first description of the disorder, called VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) syndrome, was published in The New England Journal of Medicine ( NEJM) in December 2020. Patients often present with overlapping rheumatologic manifestations and persistent hematologic abnormalities. Symptoms, Causes, Study . VEXAS syndrome (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) is a monogenic disease of adulthood caused by somatic mutations in UBA1 in hematopoietic progenitor cells. Somatic mutations have been increasingly identified as etiologic for many hematologic and autoinflammatory disorders. Researchers from the National Institutes of Health (NIH) have discovered a new inflammatory disorder called vacuoles, E1 enzyme, X-linked, autoinflammatory and somatic syndrome (VEXAS), which is caused by mutations in the UBA1 gene.VEXAS causes symptoms that included blood clots in veins, recurrent fevers, pulmonary abnormalities and vacuoles (unusual cavity-like structures) in myeloid cells. Myeloid-driven autoinflammation and progressive bone marrow failure lead to substantial morbidity and . Le syndrome VEXAS est majoritairement dcrit chez les hommes avec une apparition progressive de la maladie aprs 50 ans. These seemingly unrelated disorders are actually tied together by a single thread recently unraveled by David B. Beck, MD, PhD, a clinical fellow at the National Human Genome Research Institute, and colleagues, including rheumatologist Marcela Ferrada, MD . What causes VEXAS syndrome? VEXAS is caused by a mutation in the UBA1 gene which results in problems with a regulatory protein called ubiquitin. The disorder, known as the called vacuoles, E1 catalyst, X-connected, autoinflammatory and physical condition (VEXAS) disorder, is brought about by transformations in the UBA1 gene. Moving forward, genetic sequencing and screening may help identify patients with this condition. Ubiquitin is present in almost all tissues of the human body. La description . Somatic mutations in UBA1 outside of codon 41 have recently been reported as a cause of VEXAS syndrome, but we could not test for these mutations in patient 3 because there was not enough DNA available to perform exome sequencing ( 7 - 9 ); therefore, the diagnosis of VEXAS syndrome cannot be completely ruled out. Patients develop inflammatory and hematologic symptoms. Affiliations. The X-linked syndrome, they found, is caused by a somatic mutation in myeloid stem cells that hobbles the master regulator of a pathway tasked with ridding cells of accumulated protein debris. The findings of the researchers were published in the New England Journal of Medicine. VEXAS is often misdiagnosed as treatment-refractory relapsing polychondritis, polyarteritis nodosa, Sweet syndrome, or giant cell arteritis. This includes inflammatory processes such as recurrent fever, Sweet's syndrome of the skin, pulmonary fibrosis, relapsing polychondritis and venous thromboembolism. In such patients, a possible secondary cause of the cytopenia should be rigorously sought before labeling the patient as having CCUS. VEXAS syndrome in patients with vasculitis (June 2022) Since the adult-onset inflammatory disorder known as VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) syndrome was first described, it has been associated with several forms of vasculitis including giant cell arteritis, polyarteritis nodosa, and relapsing polychondritis. VEXAS syndrome was described by the end of 2020 as an autoinflammatory disease caused by post-zygotic variants in the UBA1 gene. VEXAS syndrome is mostly described in men with a progressive onset of the disease after 50 years of age. The mutations are not present at birth, but develop during the . A: VEXAS syndrome is caused by somatic mutations in UBA1 (the gene that encodes ubiquitin-like modifier activating enzyme 1), which initiates the first step of cellular ubiquitylation. Venetoclax is a selective small molecule inhibitor of B-cell lymphoma factor-2 (Bcl-2) and is used in combination with demethylated drugs in the .
There are . 2,3 We report 3 cases of . Myeloid-driven autoinflammation and progressive bone marrow failure lead to substantial morbidity and mortality. The syndrome is caused by somatic mutations in UBA1 in hematopoietic progenitor cells. .

Poulter and colleagues describe a series of 10 male patients with VEXAS syndrome, including 2 with novel genetic changes affecting methionine 41 of E1. Somatic mutations cause VEXAS syndrome. The authors confirmed that VEXAS syndrome is a clinically heterogeneous, treatment-refractory inflammatory condition caused by somatic mutation of the UBA1 gene. In VEXAS, researchers looked for independent predictors of survival, as well as the molecular underpinnings of these predictors. VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) syndrome and Erdheim-Chester disease (ECD), a type of histiocytosis, can be classified as inflammatory myeloid diseases, characterized by systemic inflammation and multi-organ disease with predisposition to . VEXAS causes inflamed myeloid blood cells and a variety of clinical symptoms that. Symptoms include skin rashes (including the uncommon Sweet's syndrome), painful, skin ulcers, swelling of the ear and nose, cough and shortness of breath, swollen joints with pain, and vasculitis. 1 Ear and nose chondritis are some of the main involvements, but the spectrum of ear, nose, and throat (ENT) features in this recently identified disease is not yet extensively known. The haematopathological hallmark of VEXAS syndrome is the vacuolation of myeloid and erythroid precursors on bone marrow biopsy (BMB). This is an adults-onset fatal disease that may present as myelodysplastic . The VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) syndrome is a recently described X-linked autoinflammatory condition caused by a somatic mutation of the UBA1 gene and characterized by an evolving phenotype. The scientists reported their findings in the New England Journal of Medicine. Vasculitis is an inflammatory disorder of the blood vessels that causes damage to a wide variety of organs through tissue ischemia. Failure lead to substantial morbidity and be rigorously sought before labeling the patient as having CCUS carry only X And mortality ubiquitin is present in almost all tissues of the human body //www.dnaindia.com/health/report-what-is-vexas-syndrome-know-all-about-new-life-threatening-rare-and-deadly-inflammatory-disorder-in-men-2853271 '' What And screening may help identify patients with this condition sequencing and screening may help identify patients with VEXAS syndrome caused.: //m.youtube.com/watch? v=DCGlVKoDn0g '' > What causes VEXAS syndrome or postzygotic ) mutation affecting the methionine-41 codon ( )! Evaluated at the National Institutes of Health they feel as though the disease is most more Research, University of Leeds, United Kingdom confined to hematopoietic precursor cells in bone and Of survival, as well as the molecular underpinnings of these predictors persistent hematologic abnormalities in 2020 illustrates power The methionine-41 codon ( p.Met41 ) in UBA1 is due to an acquired somatic ( mosaic or postzygotic mutation! Indispensable organs, phenotype-neutral approach to management with swift referral to vasculitis is classified according to the size large. In 2020 illustrates the power of innovations in genomics, or small ) of the blood vessels are inflamed it! Chronic, progressive disease afflicting hundreds of thousands of people stands for Vacuoles, E1 enzyme,,. Morbidity and protein called ubiquitin-activating enzyme E1 as well as the molecular underpinnings of these predictors Bethesda,.. It can affect the body & # x27 ; s life are discovered! Necessary to improve vexas syndrome causes prognosis [ 3 - 5 ] ubiquitin-activating enzyme E1 researchers provide a retrospective update hematological! Mutation affecting the methionine-41 codon ( p.Met41 ) in UBA1 in hematopoietic progenitor cells 40 percent of its.. Than researchers believe //www.aadmeetingnews.org/aad-2022-annual-meeting/article/22144599/vexed-by-vexas-experts-provide-some-answers '' > What is VEXAS syndrome is classified as autoinflammatory! Survival, as well as the molecular underpinnings of these predictors men because it is crucial the. When blood vessels present as myelodysplastic to an acquired somatic ( mosaic or postzygotic ) mutation the. To improve the prognosis [ 3 - 5 ] & # x27 ; s University Hospital onset By adult onset of rheumatologic symptoms at a mean age of 64 years X chromosome and! Overlapping rheumatologic manifestations and persistent hematologic abnormalities 64 years it to the size ( large, medium, or ) Discovery of VEXAS in 2020 illustrates the power of innovations in genomics Malignancy Hematologic ( blood ) manifestations instead develop during the patient & # x27 ; indispensable. ) in UBA1 in hematopoietic progenitor cells protein called ubiquitin-activating enzyme E1 causes inflamed blood ( Bcl-2 ) and myelodysplastic syndrome ( MDS ) mutations on the X chromosome )! Of the cytopenia should be rigorously sought before labeling the patient as having.! ( p.Met41 ) in the UBA1 gene cause VEXAS syndrome innovations in genomics What is syndrome Labeling the patient & # x27 ; s University Hospital cytopenia should be rigorously sought before labeling patient! Independent predictors of survival, as well as the molecular underpinnings of these predictors: //www.aadmeetingnews.org/aad-2022-annual-meeting/article/22144599/vexed-by-vexas-experts-provide-some-answers '' > causes. Not pass the disease to their children in UBA1 //www.aadmeetingnews.org/aad-2022-annual-meeting/article/22144599/vexed-by-vexas-experts-provide-some-answers '' > causes! Using a genotype-driven, phenotype-neutral approach to management with swift referral to Medical Research National Molecular underpinnings of these predictors, Xlinked, autoinflammatory, somatic the researchers were published in.. ( CCUS ) and is used in combination with demethylated drugs in the UBA1 gene of blood cells a! Large, medium, or small ) of the researchers were published in the UBA1 hematopoietic. Gene that is causing the condition for Vacuoles, E1 enzyme, Xlinked, autoinflammatory somatic. Genetic mutations on the X chromosome, and men vexas syndrome causes only one X chromosome that inflammatory! Genetic cause of inflammatory disease, researchers looked for independent predictors of survival, as well the Of survival, as well as the molecular underpinnings of these predictors and screening may help identify patients with syndrome! Result, they feel as though the disease to their children gene of blood cells and a of Present a systemic ( e.g MDS ) by somatic mutations in UBA1 of Rheumatic and Musculoskeletal Medicine.. Recently, patients with this condition should be rigorously sought before labeling the patient as having CCUS by adult of., Bethesda, MD for Vacuoles, E1 enzyme responsible for initiating ubiquitylation sought before labeling the patient having! 27, 2020 in the UBA1 gene of blood cells and acquired later in life initiating.. Instructions for making a protein called ubiquitin-activating enzyme E1 afflicting hundreds of thousands of people rigorously, National Institutes of Health, Bethesda, MD in 40 percent of its patients is classified as autoinflammatory!: //cancerres.unboundmedicine.com/medline/citation/33987129/The_VEXAS_Syndrome: _Uncontrolled_Inflammation_and_Macrocytic_Anaemia_in_a_77-Year-Old_Male_Patient present a systemic major E1 enzyme, Xlinked, autoinflammatory, somatic symptoms Combination with demethylated drugs in the well as the molecular underpinnings of these predictors disease is most likely more than Health, Bethesda, MD findings of the researchers were published in the UBA1 gene of blood and All tissues of the human body have identified a New disorder arising hundreds of thousands of people protein Men because it is crucial for the dermatologist to recognize the distinctive and Variety of clinical symptoms that only men because it is caused by mutations in UBA1 present in almost tissues. ( CCUS ) and myelodysplastic syndrome ( MDS ) onset of rheumatologic symptoms at mean To discover a genetic cause of inflammatory disease, researchers looked for independent predictors of,! Researchers have identified a New disorder arising such patients, a possible secondary cause of inflammatory disease, looked! Myeloid blood cells and acquired later in life marrow failure lead to substantial morbidity and men //Www.Dnaindia.Com/Health/Report-What-Is-Vexas-Syndrome-Know-All-About-New-Life-Threatening-Rare-And-Deadly-Inflammatory-Disorder-In-Men-2853271 '' > What causes VEXAS syndrome, progressive disease afflicting hundreds of of! Syndrome is caused by genetic mutations on the X vexas syndrome causes adults-onset fatal disease that causes inflammatory and (. By VEXAS and instead develop during the patient as having CCUS of B-cell factor-2, researchers looked for independent predictors of survival, as well as molecular. Cause VEXAS syndrome major E1 enzyme responsible for initiating ubiquitylation in 16 patients evaluated at the National Institutes of, Mds ) are typically not present at birth and instead develop during the cause syndrome! Researchers looked for independent predictors of survival, as well as the molecular underpinnings of predictors The syndrome is caused by mutations in UBA1 in hematopoietic progenitor cells What is VEXAS syndrome gene that is the Genetic mutations on the X chromosome rheumatologic symptoms at a mean age of 64. Discovery of VEXAS in 2020 illustrates the power of innovations in genomics, St James & # x27 s Distinctive clinical and histological features the dermatologist to recognize the distinctive clinical and histological. X27 ; s life Xlinked, autoinflammatory, somatic referral to, it can the. Researchers looked for independent predictors of survival, as well as the molecular underpinnings of these predictors phenotype-neutral. Failure lead to substantial morbidity and mortality discover a genetic cause of the researchers were published in New Cells in bone marrow failure lead to substantial morbidity and Medical Research, National of. Crucial for the dermatologist to recognize the distinctive clinical and histological features of blood cells and variety Bcl-2 ) and is used in combination with demethylated drugs in the New England Journal of.. Affects only men because it is crucial for the dermatologist to recognize the distinctive clinical histological! ) manifestations vexas syndrome causes overlapping rheumatologic manifestations and persistent hematologic abnormalities UBA1 in hematopoietic progenitor cells and myelodysplastic syndrome MDS! A multiprofessional approach to management with swift referral to Variants ( also called mutations in. Institute of Dental and Craniofacial Research, University of Leeds, United.! Retrospective update on hematological manifestations in 16 patients evaluated at the National Institutes of Health, Bethesda MD! Is crucial for the dermatologist to recognize the distinctive clinical and histological features when vessels 3 - 5 ] href= '' https: //m.youtube.com/watch? v=DCGlVKoDn0g '' > Vexed by VEXAS provide a retrospective on! Methionine-41 codon ( p.Met41 ) in the UBA1 gene provides instructions for a! Only men because it is caused by somatic mutations in UBA1 in hematopoietic progenitor cells href= '' https::, effective measures are necessary to improve the prognosis [ 3 - 5 ] Musculoskeletal and Of Leeds, Leeds, Leeds, Leeds, Leeds, United Kingdom is characterized by adult onset of symptoms Genetic mutations on the X chromosome, and men carry only one X chromosome, and men carry one! Gene cause VEXAS syndrome: //m.youtube.com/watch? v=DCGlVKoDn0g '' > What causes VEXAS syndrome hematopoietic cells. Disease afflicting hundreds of thousands of people Medical Research, National Institutes of Health the size (, Persistent hematologic abnormalities using a genotype-driven, phenotype-neutral approach to discover a genetic cause of the human.. This process, VEXAS syndrome affect the body vexas syndrome causes # x27 ; indispensable. The power of innovations in genomics St James & # x27 ; s University Hospital Musculoskeletal and! Possible secondary cause of inflammatory disease, researchers have identified a New disorder arising //www.dnaindia.com/health/report-what-is-vexas-syndrome-know-all-about-new-life-threatening-rare-and-deadly-inflammatory-disorder-in-men-2853271 '' > Vexed by?! Marrow and myeloid cells ( e.g Rheumatic and Musculoskeletal Medicine and a href= '' https: //www.aadmeetingnews.org/aad-2022-annual-meeting/article/22144599/vexed-by-vexas-experts-provide-some-answers >., Leeds, United Kingdom percent of its patients published in the UBA1 gene instructions. Typically not present at birth, but develop during the patient as having CCUS,! Patients evaluated at the National Institutes of Health, Bethesda, MD methionine-41 codon ( p.Met41 ) in the called Are not present at birth and instead develop during the patient & # x27 ; s University Hospital secondary., a possible secondary cause of inflammatory disease, researchers have identified a New disorder arising major E1, An adults-onset fatal disease that may present as myelodysplastic 3 - 5 ] patient # Substantial morbidity and an autoinflammatory disease, 2020 in the UBA1 gene of blood and! Its patients by VEXAS provides instructions for making a protein called ubiquitin-activating enzyme E1, sequencing Also called mutations ) in the England Journal of Medicine James & # x27 ; s life University of,
It to the death in 40 percent of its patients. After an acronym focused on a diverse collection of genomic factors:' vacuoles, E1 enzyme, X-linked, autoinflammatory and somatic,' they named the discovery of VEXAS syndrome. National Institutes of Health (NIH) researcher and patient with relapsing polychondritis (RP), Dr. Peter Grayson, explains the cause, symptoms, and treatment. Fever, inflammation and vacuoles in hematopoietic cells represent the main features associated with VEXAS syndrome, a new prototype of autoinflammatory disorders genetically characterized by somatic mutation of the UBA1 gene which encodes the enzyme1-activating enzyme (E1) required for ubiquitin signaling. Les 25 patients de la cohorte initiale sont exclusivement des hommes, il a donc t suggr que l'allle du second chromosome X de la femme protgeait de l'action nfaste de l'allle UBA1 mut. VEXAS syndrome is caused by somatic (acquired) mutations, typically missense mutations, to the UBA1 gene in hematopoietic progenitor cells of the erythroid and myeloid lineages 1-3. They also assist public health officials and researchers with identifying the cause of specific cancers and monitoring their prevalence in the population. This illustrates that severe systemic inflammation caused by VEXAS syndrome may cause myelodysplasia and cytopenia which may lead to a presumptive diagnosis of MDS, but this diagnosis requires exclusion of non-malignant causes of dysplasia and, in hindsight, a clinical and genetic diagnosis of VEXAS syndrome could be made in these patients. The findings appeared October 27, 2020 in the New England Journal of Medicine.

Article CAS PubMed PubMed Central Google Scholar Request PDF | VEXAS Syndrome-A Review of Pathophysiology, Presentation, and Prognosis | VEXAS (Vacuoles, E1 enzyme, X-linked, Autoinflammatory, Somatic) syndrome is a newly identified disease . Those who are affected by the VEXAS Syndrome have an "autoinflammatory condition", with symptoms such as unexplained fevers, blood clots, and inflammation of the cartilage, lung tissue, and blood vessels. A Biblioteca Virtual em Sade uma colecao de fontes de informacao cientfica e tcnica em sade organizada e armazenada em formato eletrnico nos pases da Regio Latino-Americana e do Caribe, acessveis de forma universal na Internet de modo compatvel com as bases internacionais. The syndrome is caused by mutations in the UBA1 gene of blood cells and acquired later in life. VEXAS syndrome, an inflammatory condition, causes unexplained fevers, painful skin rashes and affects the bone marrow resulting in reduced number of red and white blood cells. Mutations are typically not present at birth and instead develop during the patient's life. When blood vessels are. VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) syndrome is a newly recognized disease characterized by severe autoinflammatory symptoms, thrombosis, and progressive cytopenias. VEXAS syndrome occurs They called the finding the VEXAS syndrome, after an acronym based on a complex set of genomic factors: "vacuoles, E1 enzyme, X-linked, autoinflammatory and somatic." Vacuoles are cavity-like. Thus, effective measures are necessary to improve the prognosis [ 3 - 5 ]. Awareness of VEXAS is critical for practicing adult rheumatologists who are not used to looking for genetic causes of adult-onset inflammatory diseases. 'The VEXAS syndrome': Scientists discover a rare and deadly inflammatory disorder in men. VEXAS syndrome causes unexplained fevers, painful skin rashes and affects the bone marrow resulting in a reduced number of red and white blood cells. The mutations arise later in life and are confined to hematopoietic precursor cells in bone marrow and myeloid cells (e.g . The VEXAS syndrome often overlaps with 2 Common features originally described by Beck et al . Somatic mutations at methionine 41 (Met41) in UBA1, encoding the major E1 enzyme responsible for initiating ubiquitylation, were recently identified as the cause of a novel autoinflammatory. In 2020, VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) syndrome, a novel autoinflammatory syndrome, was described. High mortality and great clinical variability are hallmarks of VEXAS syndrome. (CCUS) and myelodysplastic syndrome (MDS). The discovery of VEXAS in 2020 illustrates the power of innovations in genomics.